Segall Bryant & Hamill LLC Decreases Stake in Pediatrix Medical Group, Inc. (NYSE:MD)

Segall Bryant & Hamill LLC decreased its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 6.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 734,786 shares of the company's stock after selling 47,093 shares during the quarter. Segall Bryant & Hamill LLC owned approximately 0.86% of Pediatrix Medical Group worth $10,647,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Nomura Asset Management Co. Ltd. increased its position in Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after buying an additional 1,220 shares during the period. GAMMA Investing LLC increased its position in Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after buying an additional 1,765 shares during the period. AlphaQuest LLC increased its position in Pediatrix Medical Group by 65.9% during the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after buying an additional 2,012 shares during the period. Tower Research Capital LLC TRC increased its position in Pediatrix Medical Group by 218.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after buying an additional 5,104 shares during the period. Finally, Squarepoint Ops LLC acquired a new position in Pediatrix Medical Group during the fourth quarter worth approximately $132,000. Hedge funds and other institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Stock Performance

Shares of NYSE:MD traded down $0.27 during trading on Friday, reaching $12.57. The company had a trading volume of 543,188 shares, compared to its average volume of 718,903. The firm has a market capitalization of $1.08 billion, a price-to-earnings ratio of -12.45, a price-to-earnings-growth ratio of 0.86 and a beta of 1.25. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.81 and a quick ratio of 1.81. The stock's fifty day moving average price is $13.87 and its 200 day moving average price is $13.87. Pediatrix Medical Group, Inc. has a fifty-two week low of $7.40 and a fifty-two week high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The firm had revenue of $458.36 million for the quarter, compared to the consensus estimate of $451.44 million. During the same period in the previous year, the business earned $0.20 earnings per share. The company's revenue for the quarter was down 7.4% compared to the same quarter last year. As a group, equities research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. UBS Group cut their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. Macquarie boosted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. Finally, Truist Financial dropped their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $16.67.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.